2bind is a contract research organization in the field of biophysical analysis. Our clients and collaborators mainly work in drug discovery (hit identification, hit validation, and hit characterization), aptamer generation, antibody development, and protein biochemistry. Our mission is to support and help our partners with our innovative biophysical services to drive their science. Four core technologies (MST, nanoDSF, BLI, and ITC) enable us to study molecular interactions in terms of affinity, kinetics, thermodynamics, and stoichiometry. We offer a broad portfolio of biophysical services including high-throughput screening, binding analysis in bioliquids (such as serum, cell lysate, or plasma) up to competition assays.